health Princess Margaret Cancer Centre's SHERLOCK Trial Aims to Predict Cancer Recurrence via Blood Test
A major Canadian-led clinical trial is investigating whether a 'liquid biopsy' blood test can detect microscopic cancer DNA after treatment, potentially preventing relapse or stopping unnecessary therapies.
